| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |